High-Risk Medicines Management - Ministry of Health

overseen and approved by the District or Health Service Drug and Therapeutics Committee(s) (however named). Protocols must include a timeframe for review. Each high-risk medicine protocol must include patient monitoring which is relevant and appropriate for the patient’s clinical circumstances. This is to ensure a timely response ................
................